WUXI BIO(02269) - 2025 Q4 - Earnings Call Transcript

WuXi Biologics (SEHK:02269) H2 2025 Earnings call March 25, 2026 08:00 AM ET Company ParticipantsChris Chen - CEOLina Fan - SVP and Head IRMing Tu - Co-CFO and EVPWillis Wu - IR ManagerConference Call ParticipantsLaurence Tam - China Healthcare AnalystLaurence TamThis call will be conducted in English. My name is Laurence Tam, China Healthcare Analyst at Morgan Stanley. Tonight, we're honored to have the management team of WuXi Biologics present to us their 2025 annual results. We have Dr. Chris Chen, who i ...